Pandemic 2009 influenza H1N1 virus vaccination: Compliance and safety in a single hemodialysis center

Renal Failure

Volumn 32, Issue 9, 2010, Pages 1044-1048

  Stavroulopoulos, Aristeidis ^a   Stamogiannos, Georgios ^a   Aresti, Vasiliki ^a  

^a IASIO Hospital   (Greece)

Author keywords

acceptance; dialysis; Greece; immunization; influenza A (H1N1); on site; side effects

Indexed keywords

IMMUNOLOGICAL ADJUVANT; INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE; PARACETAMOL; PNEUMOCOCCUS VACCINE;

AGED; ANAPHYLAXIS; ARTICLE; BELL PALSY; CHILL; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED STUDY; CONVULSION; COUGHING; DEMYELINATING DISEASE; DIARRHEA; DRUG SAFETY; ENCEPHALITIS; FEMALE; FEVER; GREECE; GUILLAIN BARRE SYNDROME; HEADACHE; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INFLUENZA A (H1N1); INFLUENZA VACCINATION; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE SWELLING; MAJOR CLINICAL STUDY; MALAISE; MALE; MYALGIA; NAUSEA; NEURITIS; NOSE CONGESTION; PANDEMIC; PATIENT ATTITUDE; PATIENT COMPLIANCE; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEASONAL INFLUENZA; SEX DIFFERENCE; SORE THROAT; VASCULITIS;

ADULT; CASE-CONTROL STUDIES; FEMALE; GREECE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PANDEMICS; PATIENT ACCEPTANCE OF HEALTH CARE; PROSPECTIVE STUDIES; RENAL DIALYSIS; VACCINATION; YOUNG ADULT;

EID: 77957260680     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2010.510232     Document Type: Article

References (22)

1. World Health Organization. New influenza A (H1N1) virus: Global epidemiological situation, June 2009. Wkly Epidemiol Rec. 2009;84:249-257.
2. ECDC Interim Guidance. Use of specific pandemic influenza vaccines during the H1N1 2009 pandemic. Stockholm: ECDC; 2009. Available at: http://www.ecdc.europa.eu/en/publications/Publications/0908-GUI-Pandemic- Influenza- Vaccines-during-the-H1N1-2009-Pandemic.pdf. Accessed January 24, 2010.
3. WHO. Weekly Epidemiological Record: Strategic Advisory Group of Experts on Immunisation (SAGE) - Report of the extraordinary meeting on the influenza A(H1N1) 2009 pandemic. Available at: http://www.who.int/wer/2009/wer8430.pdf. Accessed January 24, 2010.
4. Hellenic Center of Disease Control (KEE?). Available at: http://www.keel.org.gr/keelpno/2009/home/ierarx-hd.pdf. Accessed January 24, 2010.
5. Hellenic Center of Disease Control (KEE?). Press release 30. 2009. Available at: http://www.keel.org.gr/keelpno/2009/id907/deltio-typou-301109.pdf. Accessed January 24, 2010.
6. CDC. Use of influenza A (H1N1) 2009 monovalent vaccine: Recommendations of the advisory committee on immunization practices (ACIP), 2009. MMWR Recomm Rep. 2009; 58(RR-10): 1-8.
7. Marcelli D, Marelli C, Richards N. Influenza A(H1N1)v pandemic in the dialysis population: First wave results from an international survey. Nephrol Dial Transplant. 2009;24: 3566-3572.
8. Hellenic Center of Disease Control (KEE?). Press release 26 Jan 2010. Available at: http://www.keel.org.gr/keelpno/2010/id907/deltio-typou-20100126. pdf. Accessed January 27, 2010.
9. Wicker S, Rabenau HF, Doerr HW, Allwinn R. Influenza vaccination compliance among health care workers in a German university hospital. Infection. 2009;37:197-202.
10. Blank PR, Schwenkglenks M, Szucs TD. Disparities in influenza vaccination coverage rates by target group in five European countries: Trends over seven consecutive seasons. Infection. 2009;37:390-400.
11. Lau JT, Yeung NC, Choi KC, Cheng MY, Tsui HY, Griffiths S. Acceptability of A/H1N1 vaccination during pandemic phase of influenza A/H1N1 in Hong Kong: Population based cross sectional survey. BMJ. 2009;339:b4164.
12. WHO. Recommended viruses for influenza vaccines for use in the 2010-2011 northern hemisphere influenza season. Available at: http://www.who.int/csr/ disease/influenza/recommendations 2010-11north/en/index.html. Accessed April 20, 2010.
13. Focetria, Summary of product characteristics. Available at: http://www.ema.europa.eu/humandocs/PDFs/EPAR/focetria/emea-combined-h710en.pdf. Accessed January 24, 2010.
14. Hellenic Center of Disease Control (KEE?). Press release 21 Nov 2009. Available at: http://www.keel.org.gr/keelpno/2009/id907/deltio-211109.pdf. Accessed January 24, 2010.
15. Lam AY, Chung Y. Establishing an on-site influenza vaccination service in an assisted-living facility. J Am Pharm Assoc (2003). 2008;48:758-763.
16. Gazmararian JA, Coleman M, Prill M, et al. Influenza vaccination of health care workers: Policies and practices of hospitals in a community setting. Am J Infect Control. 2007;35: 441-447. (Pubitemid 47331964)
17. Chittaro M, Turello D, Calligaris L, et al. Impact of vaccinating HCWs on the ward and possible influence of avian flu threat. Infection. 2009;37:29-33.
18. Greenberg ME, Lai MH, Hartel GF, et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med. 2009;361:2405-2413.
19. Liang XF, Wang HQ, Wang JZ, et al. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: A multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2010;375:56-66.
20. WHO. Pandemic (H1N1) 2009 briefing note 16: Safety of pandemic vaccines: Geneva: 2009. Available at: http://www.who.int/csr/disease/swineflu/notes/ briefing-20091119/en/index.html. Accessed January 24, 2010.
21. Clark TW, Pareek M, Hoschler K, et al. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N Engl J Med. 2009;361:2424-2435.
22. Scharpé J, Peetermans WE, Vanwalleghem J, et al. Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: An open-label trial. Am J Kidney Dis. 2009;54:77-85.